首页> 美国卫生研究院文献>ISRN Dentistry >The Efficacy of Selected Desensitizing OTC Products: A Systematic Review
【2h】

The Efficacy of Selected Desensitizing OTC Products: A Systematic Review

机译:精选的脱敏非处方药产品的功效:系统评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. The aim of the present study was to review the published literature in order to identify relevant studies for inclusion and to determine whether there was any evidence on the clinical effectiveness of selected desensitizing toothpastes, calcium sodium phosphosilicate (CSPS), amorphous calcium phosphate (ACP), nanohydroxyapatite, and casein phosphopeptide-amorphous calcium phosphate (tooth mousse) on reducing dentine hypersensitivity (DH). Materials and Methods. Following a review of 593 papers identified from searching both electronic databases (PUBMED) and hand searching of relevant written journals, only 5 papers were accepted for inclusion. Results. Analysis of the included studies (3 CSPS and 2 ACP) would suggest that there may be some benefit for patients using these products for reducing DH. No direct comparative studies were available to assess all these products under the same conditions neither were there any comparative randomised controlled studies that compared at least two of these products in determining their effectiveness in treating DH. Conclusions. Due to the small number of included studies, there are limited clinical data to support any claims of clinical efficacy of these OTC products. Further studies are therefore required to determine the efficacy of these products in well-controlled RCT studies with a larger sample size.
机译:目标。本研究的目的是回顾已发表的文献,以便确定相关的纳入研究,并确定是否有证据表明所选的脱敏牙膏,磷酸硅钙钠(CSPS),无定形磷酸钙(ACP)的临床有效性。 ,纳米羟基磷灰石和酪蛋白磷酸肽无定形磷酸钙(牙齿摩丝)对降低牙本质过敏(DH)的作用。材料和方法。在对通过搜索电子数据库(PUBMED)和手工搜索相关书面期刊确定的593篇论文进行审查后,仅接受了5篇论文。结果。对纳入研究(3 CSPS和2 ACP)的分析表明,使用这些产品减少DH的患者可能会有一些益处。没有直接的比较研究可以在相同条件下评估所有这些产品,也没有任何比较的随机对照研究比较了至少两种这些产品在确定其治疗DH的有效性方面。结论。由于所纳入研究的数量很少,因此临床数据不足以支持这些OTC产品的临床功效的任何主张。因此,需要进行大量研究才能确定这些产品在具有较大样本量的受到良好控制的RCT研究中的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号